Products
16821 Results
| Quick actions | ISIN | UL | Product | Direction | SL | Ref. | Bid | Spread | Ask | Ratio | % day | % week | % month | Issue date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novartis Constant Leverage with ISIN code: CH1276587297 | Novartis | Constant Leverage | Long | ― | 98.12 | 2.87 | 0.050 | 2.92 | 1 | -1.71% | 7.49% | 1.77% | 13 Oct. 2023 | |
| Novartis Constant Leverage with ISIN code: CH1423416655 | Novartis | Constant Leverage | Short | ― | 98.12 | 2.99 | 0.080 | 3.07 | 1 | -2.61% | -24.49% | -27.07% | 12 May. 2025 | |
| Novartis Constant Leverage with ISIN code: CH1276587255 | Novartis | Constant Leverage | Short | ― | 98.12 | 0.94 | 0.030 | 0.97 | 1 | -3.09% | -12.96% | -13.76% | 13 Oct. 2023 | |
| Novartis Constant Leverage with ISIN code: CH1276587263 | Novartis | Constant Leverage | Short | ― | 98.12 | 2.6 | 0.030 | 2.63 | 1 | -1.14% | -7.80% | -7.80% | 13 Oct. 2023 | |
| Novartis Constant Leverage with ISIN code: CH1423416663 | Novartis | Constant Leverage | Short | ― | 98.12 | 3.8 | 0.090 | 3.89 | 1 | -2.31% | -20.17% | -21.97% | 12 May. 2025 | |
| Novartis Constant Leverage with ISIN code: CH1276587248 | Novartis | Constant Leverage | Short | ― | 98.12 | 0.27 | 0.030 | 0.3 | 1 | -10.00% | -22.86% | -22.86% | 13 Oct. 2023 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1276587339 | Novo Nordisk | Constant Leverage | Long | ― | 451.072 | 0.14 | 0.020 | 0.16 | 1 | -12.50% | 0.00% | -33.33% | 13 Oct. 2023 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1346000271 | Novo Nordisk | Constant Leverage | Long | ― | 451.072 | 0.056 | 0.003 | 0.059 | 1 | -5.08% | 5.66% | -29.11% | 9 Jul. 2024 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1290993042 | Novo Nordisk | Constant Leverage | Long | ― | 451.072 | 0.001 | ― | ― | 1 | 0.00% | 0.00% | 0.00% | 23 Feb. 2024 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1290993299 | Novo Nordisk | Constant Leverage | Long | ― | 451.072 | 0.001 | ― | ― | 1 | 0.00% | 0.00% | 0.00% | 11 Mar. 2024 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1396327897 | Novo Nordisk | Constant Leverage | Long | ― | 451.072 | 0.052 | 0.003 | 0.055 | 1 | -5.45% | 26.83% | -67.50% | 29 Jan. 2025 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1396327889 | Novo Nordisk | Constant Leverage | Long | ― | 451.072 | 0.46 | 0.030 | 0.49 | 1 | -6.12% | 9.52% | -44.58% | 29 Jan. 2025 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1276587321 | Novo Nordisk | Constant Leverage | Short | ― | 451.072 | 6.53 | 0.090 | 6.62 | 1 | -1.36% | -12.93% | 7.76% | 13 Oct. 2023 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1290993018 | Novo Nordisk | Constant Leverage | Short | ― | 451.072 | 0.92 | 0.030 | 0.95 | 1 | -3.16% | -20.69% | 1.10% | 23 Feb. 2024 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1423415707 | Novo Nordisk | Constant Leverage | Short | ― | 451.072 | 3.89 | 0.120 | 4.01 | 1 | -2.99% | -26.05% | -8.90% | 7 May. 2025 | |
| Nvidia Constant Leverage with ISIN code: CH1119068000 | Nvidia | Constant Leverage | Long | ― | 157.844 | 103.51 | 0.660 | 104.17 | 1 | -0.63% | -3.62% | 45.38% | 12 May. 2022 | |
| Nvidia Constant Leverage with ISIN code: CH1199369815 | Nvidia | Constant Leverage | Long | ― | 157.844 | 14.27 | 0.090 | 14.36 | 1 | -0.63% | -4.68% | 58.56% | 27 Jun. 2022 | |
| Nvidia Constant Leverage with ISIN code: CH1246614460 | Nvidia | Constant Leverage | Long | ― | 157.844 | 2.1 | 0.030 | 2.13 | 1 | -1.41% | -6.25% | 69.35% | 3 Feb. 2023 | |
| Nvidia Constant Leverage with ISIN code: CH1246615640 | Nvidia | Constant Leverage | Long | ― | 157.844 | 0.38 | 0.030 | 0.41 | 1 | -7.32% | -9.52% | 58.33% | 8 Jun. 2023 | |
| Nvidia Constant Leverage with ISIN code: CH1423415673 | Nvidia | Constant Leverage | Long | ― | 157.844 | 93.45 | 1.290 | 94.74 | 1 | -1.36% | -13.42% | 123.08% | 7 May. 2025 |
The underlying prices shown are not real-time prices, i.e. they are delayed due to legal requirements of the data provider. As a consequence, the price of the product on a specific underlying may substantially differ from the price of the product that you would expect on the basis of the underlying price displayed.